Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
OptiNose (Norway)
h-index: 25
Total citations: 2,524
Total papers: 53
Homepage:
http://www.optinose.com/
Recent papers from OptiNose (Norway)
Development of computational fluid dynamics methodology for characterization of exhalation delivery system performance in a nasal airway with Draf-III surgery
Journal of Aerosol Science · 2022
Endoscopic grading systems for nasal polyps: are we comparing apples to oranges?
Rhinology Journal · 2022
Role of Nasal Casts for In Vitro Evaluation of Nasal Drug Delivery and Quantitative Evaluation of Various Nasal Casts
Therapeutic Delivery · 2020
EXHANCE-3: a cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps
Rhinology Journal · 2019
Deposition of drugs in the nose and sinuses with an exhalation delivery system vs conventional nasal spray or high-volume irrigation in Draf II/III post-surgical anatomy
Rhinology Journal · 2019
NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps
American Journal of Rhinology and Allergy · 2018
Evidence for Intranasal Oxytocin Delivery to the brain: Recent Advances and Future Perspectives
Therapeutic Delivery · 2018
NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis
Journal of Allergy and Clinical Immunology · 2018
EXHANCE‐12: 1‐year study of the exhalation delivery system with fluticasone (EDS‐FLU) in chronic rhinosinusitis
International Forum of Allergy & Rhinology · 2018
Evidence for intranasal oxytocin delivery to the brain: recent advances and future perspectives
2018
Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial
Psychoneuroendocrinology · 2016
Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment
Translational Psychiatry · 2015
AVP ‐825 Breath‐Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks
Headache The Journal of Head and Face Pain · 2015
A Randomized, Double‐Blind, Placebo‐Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder ( AVP ‐825) in the Treatment of Acute Migraine (The TARGET Study)
Headache The Journal of Head and Face Pain · 2014
The Nasal Approach to Delivering Treatment for Brain Diseases: An Anatomic, Physiologic, and Delivery Technology Overview
Therapeutic Delivery · 2014
Breath Powered Nasal Delivery: A New Route to Rapid Headache Relief
Headache The Journal of Head and Face Pain · 2013
Improved Pharmacokinetics of Sumatriptan With B reath P owered™ Nasal Delivery of Sumatriptan Powder
Headache The Journal of Head and Face Pain · 2013
Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review
Drug Delivery and Translational Research · 2012
Nasal Deposition and Clearance in Man: Comparison of a Bidirectional Powder Device and a Traditional Liquid Spray Pump
Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2012
Computational Fluid Dynamics (Cfd) Applied in the Drug Delivery Design Process to the Nasal Passages: A Review
Journal of Mechanics in Medicine and Biology · 2011